BIVDA Press Releases

15Jan

BIVDA response to Parliament’s vote on the Brexit deal

Today the House of Commons voted down the EU withdrawal agreement and the framework for the future relationship.

Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Today’s vote casts a shadow of uncertainty over the UK’s future relationship with the EU. The IVD industry remains anxious about access for patients to essential diagnostic tests if there is no transition period after 29 March. We therefore call for positive steps to be taken in these testing times and urge Government and policy makers to provide clarity and create sufficient space for our sector so that it is able to meet the significant challenge of ensuring the supply of essential diagnostics tests to patients through 2019.”

For a copy of BIVDA's position paper on Brexit, click here.

Related

Lab Innovations 2018 – the home of new laboratory product launches

Twickenham, UK – 11th October, 2018 – Lab Innovations, the UK’s only trade show dedicated to the ...

Read More >

UK Continues to Lag EU Market for In-Vitro Diagnostic Expenditure

The European IVD Market Statistics Report 2016 has been published by MedTech Europe and is available...

Read More >

BIVDA joins declaration by industry on combating antimicrobial resistance

BIVDA has joined more than 80 leading international pharmaceutical, generics, diagnostics and biotec...

Read More >

BIVDA Celebrates Milestone 25th Anniversary

The British In Vitro Diagnostics Association (BIVDA) celebrated its milestone 25th Anniversary on Mo...

Read More >

PwC analysis highlights economic footprint of UK Life Sciences

The productivity of the UK’s Life Sciences sector is more than double the UK average, says a new re...

Read More >

MedTech Week: showcasing life-changing technologies across Europe

For the fourth year running, MedTech Week is bringing together medtech companies and national associ...

Read More >